Equities research analysts expect that Genpact Limited (NYSE:G) will report $0.41 earnings per share for the current quarter, Zacks Investment Research reports. Seven analysts have made estimates for Genpact’s earnings, with the highest EPS estimate coming in at $0.42 and the lowest estimate coming in at $0.40. Genpact reported earnings of $0.43 per share in the same quarter last year, which would indicate a negative year-over-year growth rate of 4.7%. The firm is expected to announce its next earnings report after the market closes on Monday, February 12th.
On average, analysts expect that Genpact will report full year earnings of $1.60 per share for the current fiscal year, with EPS estimates ranging from $1.59 to $1.62. For the next year, analysts anticipate that the firm will post earnings of $1.77 per share, with EPS estimates ranging from $1.65 to $1.81. Zacks Investment Research’s earnings per share averages are an average based on a survey of analysts that that provide coverage for Genpact.
Genpact (NYSE:G) last released its quarterly earnings results on Tuesday, November 7th. The business services provider reported $0.46 EPS for the quarter, topping the consensus estimate of $0.36 by $0.10. The company had revenue of $708.82 million for the quarter, compared to analyst estimates of $685.25 million. Genpact had a return on equity of 23.86% and a net margin of 10.18%. The firm’s revenue was up 9.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.37 earnings per share.
Genpact (NYSE G) opened at $34.33 on Tuesday. The company has a market capitalization of $6,710.15, a P/E ratio of 24.88, a price-to-earnings-growth ratio of 2.16 and a beta of 0.58. Genpact has a 12-month low of $23.34 and a 12-month high of $34.79. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.65 and a current ratio of 1.65.
In related news, insider Mohit Thukral sold 25,000 shares of Genpact stock in a transaction that occurred on Tuesday, November 28th. The stock was sold at an average price of $32.25, for a total value of $806,250.00. Following the sale, the insider now directly owns 85,305 shares in the company, valued at $2,751,086.25. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, insider Private Ltd Gic sold 1,499,806 shares of Genpact stock in a transaction that occurred on Monday, November 20th. The shares were sold at an average price of $30.26, for a total value of $45,384,129.56. The disclosure for this sale can be found here. In the last three months, insiders sold 1,654,797 shares of company stock worth $50,356,184. Corporate insiders own 1.41% of the company’s stock.
Several institutional investors have recently bought and sold shares of the stock. Commerzbank Aktiengesellschaft FI boosted its stake in shares of Genpact by 13.7% in the fourth quarter. Commerzbank Aktiengesellschaft FI now owns 18,726 shares of the business services provider’s stock valued at $594,000 after buying an additional 2,260 shares in the last quarter. Robeco Institutional Asset Management B.V. purchased a new stake in Genpact during the fourth quarter worth $38,064,000. Boston Advisors LLC purchased a new stake in Genpact during the fourth quarter worth $1,014,000. Jag Capital Management LLC purchased a new stake in Genpact during the fourth quarter worth $11,430,000. Finally, First Manhattan Co. purchased a new stake in Genpact during the fourth quarter worth $322,000. Hedge funds and other institutional investors own 91.48% of the company’s stock.
Genpact Company Profile
Genpact Limited is engaged in providing digitally powered business process management and services. The Company is also engaged in designing, transforming and running a combination of processes, as well as providing solutions that combine elements of its service offerings. The Company’s segments include Business process outsourcing and Information technology services.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.